Physician profile
Mark A Biebel
NPI 1356310528
$1,128.57
in general payments reported to CMS, 2019-2025
11 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $39.52 · 2021: $112 · 2022: $294 · 2023: $381 · 2024: $129 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $682.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $682.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $522.36 | 2022-2023 | Ortholoc 3di, Am, Actishield |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $240.56 | 2021-2025 | Jublia |
| Seapearl East, INC | $133.47 | 2025 | |
| Sumitomo Pharma America, INC. | $97.65 | 2024 | Gemtesa |
| Integra Lifesciences Corporation | $27.83 | 2020 | |
| Bioventus LLC | $22.73 | 2021 | |
| Bone Support INC. | $22.00 | 2025 | Ceramentbone Void Filler, Cerament G |
| Kerecis Limited | $18.34 | 2022 | |
| Smith+Nephew, INC. | $17.42 | 2021 | |
| Treace Medical Concepts, INC. | $14.52 | 2024 | |
| Misonix INC | $11.69 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Biebel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.